Phoebe Hildreth Yager, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units, Pediatric | 16 | 2024 | 986 | 2.690 |
Why?
|
Telemedicine | 8 | 2020 | 2849 | 1.000 |
Why?
|
Teaching Rounds | 2 | 2020 | 267 | 0.960 |
Why?
|
Critical Care | 7 | 2023 | 2634 | 0.890 |
Why?
|
Hyperkalemia | 2 | 2021 | 215 | 0.740 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 108 | 0.680 |
Why?
|
Professional-Family Relations | 2 | 2020 | 479 | 0.650 |
Why?
|
Naloxone | 1 | 2021 | 358 | 0.650 |
Why?
|
Hyponatremia | 1 | 2021 | 274 | 0.620 |
Why?
|
Hospitals, Pediatric | 4 | 2023 | 1795 | 0.620 |
Why?
|
Intracranial Pressure | 1 | 2020 | 315 | 0.610 |
Why?
|
Intracranial Hypertension | 1 | 2020 | 183 | 0.600 |
Why?
|
Emergency Medicine | 3 | 2017 | 1199 | 0.560 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 414 | 0.560 |
Why?
|
Hospital Rapid Response Team | 1 | 2016 | 56 | 0.520 |
Why?
|
Documentation | 1 | 2021 | 863 | 0.500 |
Why?
|
Videoconferencing | 1 | 2017 | 189 | 0.500 |
Why?
|
Sodium | 1 | 2020 | 1578 | 0.490 |
Why?
|
Heparin | 1 | 2022 | 1632 | 0.490 |
Why?
|
Manikins | 2 | 2017 | 235 | 0.480 |
Why?
|
Patient Care Team | 6 | 2020 | 2457 | 0.480 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2014 | 57 | 0.470 |
Why?
|
Babesia microti | 1 | 2014 | 31 | 0.460 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.430 |
Why?
|
Tachycardia, Ventricular | 1 | 2021 | 1206 | 0.430 |
Why?
|
Quality Improvement | 3 | 2024 | 3666 | 0.420 |
Why?
|
Pediatrics | 5 | 2020 | 3489 | 0.410 |
Why?
|
After-Hours Care | 1 | 2012 | 99 | 0.400 |
Why?
|
Blood | 1 | 2014 | 581 | 0.390 |
Why?
|
Intensive Care Units | 3 | 2023 | 3660 | 0.390 |
Why?
|
Child | 31 | 2024 | 77344 | 0.380 |
Why?
|
Neurologic Examination | 1 | 2014 | 917 | 0.380 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 207 | 0.350 |
Why?
|
Shock | 2 | 2021 | 316 | 0.350 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3759 | 0.340 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2475 | 0.320 |
Why?
|
Physical Examination | 1 | 2014 | 1211 | 0.320 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2022 | 599 | 0.300 |
Why?
|
Mannose-Binding Lectin | 1 | 2008 | 145 | 0.280 |
Why?
|
Thromboembolism | 1 | 2012 | 982 | 0.270 |
Why?
|
Curriculum | 4 | 2024 | 3543 | 0.270 |
Why?
|
Airway Management | 3 | 2021 | 323 | 0.260 |
Why?
|
Infant | 15 | 2024 | 34948 | 0.250 |
Why?
|
Anemia | 1 | 2014 | 1470 | 0.240 |
Why?
|
Electronic Health Records | 1 | 2021 | 4460 | 0.240 |
Why?
|
Parents | 2 | 2019 | 3392 | 0.240 |
Why?
|
Intubation, Intratracheal | 3 | 2021 | 1355 | 0.230 |
Why?
|
Multilingualism | 1 | 2024 | 86 | 0.220 |
Why?
|
Boston | 5 | 2020 | 9150 | 0.220 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2213 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 2997 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3105 | 0.210 |
Why?
|
Child, Preschool | 13 | 2024 | 40812 | 0.200 |
Why?
|
Cities | 1 | 2023 | 509 | 0.190 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1004 | 0.190 |
Why?
|
Physicians | 1 | 2019 | 4480 | 0.190 |
Why?
|
Waste Management | 1 | 2020 | 19 | 0.180 |
Why?
|
Otolaryngology | 2 | 2020 | 647 | 0.180 |
Why?
|
Respiratory System | 2 | 2020 | 550 | 0.180 |
Why?
|
Organizational Policy | 2 | 2020 | 421 | 0.170 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 113 | 0.170 |
Why?
|
Humans | 44 | 2024 | 735458 | 0.170 |
Why?
|
Bioethical Issues | 1 | 2020 | 118 | 0.170 |
Why?
|
Containment of Biohazards | 1 | 2019 | 37 | 0.170 |
Why?
|
Bioethics | 1 | 2020 | 115 | 0.160 |
Why?
|
Brain Injuries | 2 | 2008 | 2018 | 0.160 |
Why?
|
Critical Illness | 4 | 2022 | 2648 | 0.160 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.160 |
Why?
|
Dexmedetomidine | 2 | 2014 | 314 | 0.160 |
Why?
|
Inservice Training | 1 | 2019 | 380 | 0.140 |
Why?
|
Adolescent | 13 | 2021 | 85125 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 644 | 0.140 |
Why?
|
Outsourced Services | 1 | 2016 | 20 | 0.140 |
Why?
|
Narcotic Antagonists | 1 | 2021 | 553 | 0.140 |
Why?
|
Hospital Administration | 1 | 2020 | 347 | 0.140 |
Why?
|
Respiration, Artificial | 3 | 2024 | 2559 | 0.140 |
Why?
|
Angiography | 1 | 2022 | 1601 | 0.140 |
Why?
|
Rabies Vaccines | 1 | 2015 | 30 | 0.130 |
Why?
|
Rabies virus | 1 | 2015 | 33 | 0.130 |
Why?
|
Transportation of Patients | 1 | 2016 | 174 | 0.130 |
Why?
|
Respiratory Therapy | 1 | 2015 | 123 | 0.130 |
Why?
|
Male | 21 | 2024 | 346169 | 0.130 |
Why?
|
Rabies | 1 | 2015 | 57 | 0.120 |
Why?
|
Emergency Treatment | 1 | 2019 | 498 | 0.120 |
Why?
|
Postoperative Care | 2 | 2011 | 1464 | 0.120 |
Why?
|
Hypnotics and Sedatives | 2 | 2014 | 1160 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1375 | 0.120 |
Why?
|
Developing Countries | 3 | 2024 | 2754 | 0.120 |
Why?
|
Environment | 1 | 2020 | 1105 | 0.120 |
Why?
|
Tick-Borne Diseases | 1 | 2014 | 34 | 0.120 |
Why?
|
Female | 19 | 2024 | 376708 | 0.110 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2019 | 415 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1474 | 0.110 |
Why?
|
Dysarthria | 1 | 2012 | 57 | 0.110 |
Why?
|
Hypokalemia | 1 | 2013 | 151 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2022 | 76887 | 0.100 |
Why?
|
Child Mortality | 1 | 2024 | 199 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2086 | 0.100 |
Why?
|
Patient Transfer | 2 | 2016 | 742 | 0.100 |
Why?
|
Basilar Artery | 1 | 2012 | 197 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 681 | 0.100 |
Why?
|
Infection Control | 1 | 2019 | 960 | 0.100 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5176 | 0.100 |
Why?
|
Brain Death | 2 | 2012 | 335 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1346 | 0.090 |
Why?
|
Communication | 2 | 2017 | 3748 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 623 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 1965 | 0.090 |
Why?
|
Hypovolemia | 1 | 2010 | 42 | 0.090 |
Why?
|
Homocystinuria | 1 | 2010 | 65 | 0.090 |
Why?
|
Ataxia | 1 | 2012 | 304 | 0.090 |
Why?
|
Stroke | 1 | 2012 | 9458 | 0.090 |
Why?
|
Quality Control | 1 | 2012 | 817 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2019 | 1720 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2461 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4556 | 0.080 |
Why?
|
Pilot Projects | 3 | 2017 | 8256 | 0.080 |
Why?
|
Liver Failure, Acute | 1 | 2010 | 166 | 0.080 |
Why?
|
Adult | 7 | 2023 | 212371 | 0.080 |
Why?
|
Patient Simulation | 1 | 2011 | 302 | 0.080 |
Why?
|
Coma | 1 | 2012 | 485 | 0.080 |
Why?
|
Hospitalists | 1 | 2012 | 291 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2016 | 970 | 0.080 |
Why?
|
Observer Variation | 1 | 2014 | 2559 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12840 | 0.080 |
Why?
|
Death | 1 | 2012 | 649 | 0.080 |
Why?
|
Leukoencephalopathies | 1 | 2010 | 235 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2394 | 0.080 |
Why?
|
Problem-Based Learning | 1 | 2011 | 348 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2017 | 5017 | 0.070 |
Why?
|
Complement C4 | 1 | 2007 | 252 | 0.070 |
Why?
|
Brain Edema | 2 | 2008 | 598 | 0.070 |
Why?
|
Fever | 1 | 2014 | 1599 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 580 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 725 | 0.070 |
Why?
|
Complement Activation | 1 | 2008 | 444 | 0.070 |
Why?
|
Larynx | 1 | 2010 | 494 | 0.070 |
Why?
|
Complement C3 | 1 | 2008 | 457 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 926 | 0.070 |
Why?
|
Vision Disorders | 1 | 2012 | 1055 | 0.060 |
Why?
|
Prospective Studies | 5 | 2017 | 52611 | 0.060 |
Why?
|
Skin Diseases | 1 | 2014 | 1074 | 0.060 |
Why?
|
Shock, Cardiogenic | 1 | 2010 | 655 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15306 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3366 | 0.060 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 868 | 0.060 |
Why?
|
Checklist | 1 | 2011 | 796 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 425 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2015 | 3031 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2015 | 2138 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8241 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1159 | 0.060 |
Why?
|
Shock, Septic | 1 | 2010 | 767 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2020 | 25403 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2010 | 1519 | 0.050 |
Why?
|
Heart Rate | 1 | 2014 | 3980 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 1988 | 647 | 0.050 |
Why?
|
Cell Death | 1 | 2008 | 1661 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2694 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7065 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2015 | 2942 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6932 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7652 | 0.050 |
Why?
|
Communication Barriers | 1 | 2024 | 401 | 0.050 |
Why?
|
Recycling | 1 | 2020 | 15 | 0.050 |
Why?
|
Medical Waste | 1 | 2020 | 14 | 0.050 |
Why?
|
Disease Management | 1 | 2011 | 2407 | 0.050 |
Why?
|
Blood Pressure | 2 | 2014 | 8258 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2020 | 42 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4070 | 0.040 |
Why?
|
Movement | 1 | 2007 | 1463 | 0.040 |
Why?
|
El Salvador | 1 | 2019 | 34 | 0.040 |
Why?
|
Sepsis | 1 | 2014 | 2568 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19673 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 56151 | 0.040 |
Why?
|
Anesthesia | 1 | 2010 | 1547 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14501 | 0.040 |
Why?
|
United States | 5 | 2021 | 69005 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2012 | 3019 | 0.040 |
Why?
|
Africa, Western | 1 | 2019 | 157 | 0.040 |
Why?
|
Patient Isolation | 1 | 2019 | 95 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2024 | 13817 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 279 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6084 | 0.040 |
Why?
|
Recovery of Function | 1 | 2008 | 2875 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 530 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2016 | 67 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2008 | 14147 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2092 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2818 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 70952 | 0.030 |
Why?
|
Ecuador | 1 | 2014 | 52 | 0.030 |
Why?
|
Video Recording | 1 | 2019 | 926 | 0.030 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 100 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1792 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2015 | 284 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 333 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7159 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1196 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3296 | 0.030 |
Why?
|
Tissue Donors | 2 | 2015 | 2161 | 0.020 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 638 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6364 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2015 | 562 | 0.020 |
Why?
|
Clinical Competence | 2 | 2019 | 4599 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2259 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2012 | 284 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2841 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 13734 | 0.020 |
Why?
|
Alamethicin | 1 | 1988 | 2 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 772 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8475 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8500 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1641 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1351 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 17700 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 39931 | 0.020 |
Why?
|
Electric Conductivity | 1 | 1988 | 405 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3465 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 62430 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 1988 | 376 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13074 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1810 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10203 | 0.020 |
Why?
|
Electrodes | 1 | 1988 | 603 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4846 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17201 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 693 | 0.020 |
Why?
|
Safety Management | 1 | 2011 | 763 | 0.020 |
Why?
|
Surface Properties | 1 | 1988 | 1164 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2432 | 0.020 |
Why?
|
Maze Learning | 1 | 2007 | 470 | 0.020 |
Why?
|
Calcium Channels | 1 | 1988 | 602 | 0.020 |
Why?
|
Registries | 1 | 2020 | 7932 | 0.020 |
Why?
|
Health Personnel | 1 | 2017 | 3153 | 0.010 |
Why?
|
Mice | 2 | 2008 | 79548 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3475 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20493 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3825 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 38356 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10690 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10011 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1126 | 0.010 |
Why?
|
Animals | 3 | 2008 | 165479 | 0.010 |
Why?
|
Ligands | 1 | 1988 | 3248 | 0.010 |
Why?
|
Equipment Design | 1 | 1988 | 3499 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1813 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6216 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4593 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2805 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1848 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 211305 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11203 | 0.010 |
Why?
|
Inflammation | 1 | 2007 | 10521 | 0.000 |
Why?
|